BRKRP // Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A
OWN <GO> NASDAQ CIK 0001109354 ↗ Health Care • Biotechnology: Laboratory Analytical Instruments
$454.20 ▼ -1.23
(-0.27%)
MKT CAP: $69.20B • VOL: 16.2K
52W L $264 52W H $485
DISCLOSED BUY FLOW
$0
DISCLOSED SELL FLOW
$0
13F HEDGE FUND FILINGS
0 DISCLOSURES
CONGRESSIONAL STOCK ACT
0 FILINGS
BRKRP // SEC FORM 4 INSIDERS, 13F WHALES & POLITICIAN LEDGER (OWN <GO>)
WHALE DIRECTORY <13F>
| FILING DATE | FILER / INSTITUTION | CATEGORY | ACTION | SHARES | EXEC PRICE | TOTAL VALUE | DOSSIER |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | Citadel Advisors LLC (13F-HR) Institutional Investment Manager | HEDGE_FUND | BUY | 425.0K | $436.03 | $185.3M | TRACK <GO> |
| 2025-02-04 | Executive Officer Form 4 Trust EVP & Chief Financial Officer | INSIDER | SELL | 18.5K | $458.74 | $8.5M | TRACK <GO> |
| 2025-01-28 | Renaissance Technologies LLC 13F Quantitative Holdings | HEDGE_FUND | BUY | 190.0K | $426.95 | $81.1M | TRACK <GO> |